Esophagus carcinoma in situ
MONDO:0004708Stage 0 includes: For squamous cell carcinoma: Tis (HGD), N0, M0, G1, GX, Tumor location: Any. For adenocarcinoma: Tis (HGD), N0, M0, G1, GX. Tis: High-grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.)
Also known as: carcinoma in situ of esophagus, carcinoma in situ of oesophagus, esophageal carcinoma in situ, esophageal carcinoma in situ aJCC v7, esophagus in situ carcinoma, oesophagus in situ carcinoma, severe esophageal dysplasia, severe esophageal dysplasia aJCC v7
2893 clinical trials for this condition and its sub-types, 13 tagged with Esophagus carcinoma in situ itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Glowing dye could reveal invisible cancer clues in the esophagus
Diagnosis Not yet recruitingThis study tests whether a fluorescent tracer called WGA-800CW can make precancerous or cancerous cells in Barrett's esophagus glow during endoscopy. The tracer is sprayed onto the esophagus, and special cameras detect the glow. The goal is to find the best dose and see if this m…
Phase 1 • Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
French study to track endoscopic surgery for early esophageal cancer in 750 patients
Knowledge-focused Not yet recruitingThis study will follow 750 adults in France who undergo endoscopic submucosal dissection (ESD) for early esophageal cancer or precancerous Barrett's esophagus. Researchers will track how well the procedure removes the cancer, how often it comes back, and whether additional treatm…
Sponsor: Société Française d'Endoscopie Digestive • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC